|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/095 | |
| A61K 39/39 | |||
| A61K 31/4375 | |||
| A61K 31/66 | |||
| A61K 33/08 | |||
| A61K 33/42 | |||
| A61K 45/06 |
| (11) | Patento numeris | 2459216 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10766332.0 |
| Europos patento paraiškos padavimo data | 2010-09-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-06-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-10-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2010/002386 |
| Data | 2010-09-01 |
| (87) | Numeris | WO 2011/027222 |
| Data | 2011-03-10 |
| (30) | Numeris | Data | Šalis |
| 239156 P | 2009-09-02 | US |
| (72) |
SINGH, Manmohan, US
SKIBINSKI, David, IT
CIANETTI, Simona, IT
DORO, Francesco, IT
JAIN, Siddhartha, US
O`HAGAN, Derek, Thomas, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | IMMUNOGENIC COMPOSITIONS INCLUDING TLR ACTIVITY MODULATORS |
| IMMUNOGENIC COMPOSITIONS INCLUDING TLR ACTIVITY MODULATORS |